Disclosure of adverse events in the United States and Canada: an update, and a proposed framework for improvement by Albert W. Wu, Dennis J. Boyle, Gordon Wallace, Kathleen M. Mazor

Connect to this object online.

Motivating deprescribing conversations for patients with Alzheimer's disease and related dementias: a descriptive study by Mary T. Antonelli, John S. Cox, Cassandra Saphirak, Jerry H. Gurwitz, Sonal Singh, Kathleen M. Mazor

Connect to this object online.

Association of spatial proximity to fixed-site syringe services programs with HCV serostatus and injection equipment sharing practices among people who inject drugs in rural New En... by Eric Romo, Thomas J. Stopka, Bill M. Jesdale, Bo Wang, Kathleen M. Mazor, Peter D. Friedmann

Connect to this object online.

COVID-19 clinical trials: who is likely to participate and why? by Kimberly A Fisher, Mara M Epstein, Ngoc Nguyen, Hassan Fouayzi, Sybil Crawford, Benjamin P Linas, Kathleen M Mazor

Connect to this object online.

Prescribing cascades in persons with Alzheimer's disease: engaging patients, caregivers, and providers in a qualitative evaluation of print educational materials by Sarah Bloomstone, Kathryn Anzuoni, Noelle Cocoros, Jerry H. Gurwitz, Kevin Haynes, Vinit P. Nair, Richard Platt, Paula A. Rochon, Sonal Singh, Kathleen M. Mazor

Connect to this object online.

Long COVID awareness and receipt of medical care: a survey among populations at risk for disparities by Kimberly A. Fisher, Kimberly A. Fisher, Kathleen M. Mazor, Mara M. Epstein, Lydia Goldthwait, Hiba Abu Ghazaleh, Yanhua Zhou, Sybil Crawford, Jai Marathe, Jai Marathe, Benjamin P. Linas, Benjamin P. Linas, Benjamin P. Linas

Connect to this object online.